Successful Treatment of Recurrent Pericarditis With Rilonacept in Acute Promyelocytic Leukemia
- PMID: 38094210
- PMCID: PMC10715930
- DOI: 10.1016/j.jaccas.2023.102043
Successful Treatment of Recurrent Pericarditis With Rilonacept in Acute Promyelocytic Leukemia
Abstract
A 40-year-old woman presented with recurrent pericarditis and pericardial effusion while receiving treatment with all-trans retinoic acid and arsenic trioxide for recently diagnosed acute promyelocytic leukemia. She was successfully treated with the interleukin-1 inhibitor rilonacept after experiencing multiple recurrences with triple therapy with aspirin, colchicine, and steroids. (Level of Difficulty: Advanced.).
Keywords: acute promyelocytic leukemia; all-trans retinoic acid; arsenic trioxide therapy; pericarditis.
© 2023 The Authors.
Conflict of interest statement
Dr Klein has received research funding from Kiniksa Pharmaceuticals, Ltd; and has served on scientific advisory boards for Kiniksa Pharmaceuticals, Ltd, Swedish Orphan Biovitrum AB, Cardiol Therapeutics, and Pfizer, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Lo-Coco F., Avvisati G., Vignetti M., et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111–121. - PubMed
-
- Frankel S.R., Eardley A., Lauwers G., et al. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med. 1992;117(4):292–296. - PubMed
-
- Stahl M., Tallman M.S. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157–162. - PubMed
-
- Işık P., Çetin I., Tavil B., et al. All-transretinoic acid (ATRA) treatment-related pancarditis and severe pulmonary edema in a child with acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2010;32(8):e346–e348. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
